Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 18 for Breast cancer in women
  1. ... types of cancer, such as a form of breast cancer in women that begins in the milk-producing glands (lobular ... a 40 to 50 percent chance of lobular breast cancer in women, a slightly increased risk of prostate cancer in ...
  2. ... that have been shown to be involved in breast cancer. However, women who have a specific CYB5R3 gene polymorphism that ... the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women. Cancer Causes Control. 2014 Nov;25(11):1513- ...
  3. ... CDH1 gene mutations also occur commonly in lobular breast cancers in women without a family history of the disease. These ... of developing stomach (gastric) cancer in their lifetimes. Women with these ... lobular breast cancer (described above). People with HDGC caused by CDH1 ...
  4. ... Noninherited (somatic) PTEN gene mutations occur in some breast cancers in women without a family history of the disease. Somatic mutations are not inherited and do not occur as part of a familial cancer ... in the breast. These mutations impair the tumor suppressor function of ...
  5. ... a person's chance of developing cancer. Although breast cancer is more common in women than in men, the mutated gene can be ...
  6. ... are often said to be affected by hereditary breast and ovarian cancer syndrome. Women with BRCA1 gene mutations have a 35 to ...
  7. ... are often said to be affected by hereditary breast and ovarian cancer syndrome. Women with BRCA2 gene mutations have an approximately 12 ...
  8. ... Telli M, Pochebit SM, Lypas G, Garber JE. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat. 2012 Jun;133(3):1125-30. ...
  9. ... 01 increases the risk of liver damage in women with advanced breast cancer treated with a drug called lapatinib. Researchers suggest ... major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J Clin Oncol. 2011 Feb 20;29(6): ...
  10. ... M. Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China. Genet Mol Res. 2012 Dec ...
previous · 1 · 2 · next